IBER
Price:
$10.18
Market Cap:
$175.60M
Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.
Industry
Shell Companies
IPO Date
Stock Exchange
NYSE
Ticker
IBER
According to Ibere Pharmaceuticals’s latest financial reports and current stock price. The company's current Current Ratio is 1.86. This represents a change of 93.16% compared to the average of 0.96 of the last 4 quarters.
The mean historical Current Ratio of Ibere Pharmaceuticals over the last ten years is 1.06. The current 1.86 Current Ratio has changed 17.39% with respect to the historical average. Over the past ten years (40 quarters), IBER's Current Ratio was at its highest in in the June 2021 quarter at 5.77. The Current Ratio was at its lowest in in the September 2022 quarter at 0.24.
Average
1.06
Median
1.06
Minimum
0.27
Maximum
1.86
Discovering the peaks and valleys of Ibere Pharmaceuticals Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 597.62%
Maximum Annual Current Ratio = 1.86
Minimum Annual Increase = 0%
Minimum Annual Current Ratio = 0.27
| Year | Current Ratio | Change |
|---|---|---|
| 2021 | 1.86 | 597.62% |
The current Current Ratio of Ibere Pharmaceuticals (IBER) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.06
5-year avg
1.06
10-year avg
1.06
Ibere Pharmaceuticals’s Current Ratio is less than Parabellum Acquisition Corp. (2.89), greater than Enphys Acquisition Corp. (0.14), greater than Slam Corp. (0.08), less than Bridgetown Holdings Limited (0), greater than Tristar Acquisition I Corp. (1.06), greater than Learn CW Investment Corporation (0.11), less than Vector Acquisition Corporation (3.18), greater than AP Acquisition Corp. (0.03), less than Fusion Acquisition Corp. II (0),
| Company | Current Ratio | Market cap |
|---|---|---|
| 2.89 | $178.79M | |
| 0.14 | $163.71M | |
| 0.08 | $261.27M | |
| 0 | $184.30M | |
| 1.06 | $187.64M | |
| 0.11 | $164.01M | |
| 3.18 | $5.53B | |
| 0.03 | $178.79M | |
| 0 | $178.07M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ibere Pharmaceuticals using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ibere Pharmaceuticals or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Ibere Pharmaceuticals's Current Ratio?
How is the Current Ratio calculated for Ibere Pharmaceuticals (IBER)?
What is the highest Current Ratio for Ibere Pharmaceuticals (IBER)?
What is the 3-year average Current Ratio for Ibere Pharmaceuticals (IBER)?
What is the 5-year average Current Ratio for Ibere Pharmaceuticals (IBER)?
How does the current Current Ratio for Ibere Pharmaceuticals (IBER) compare to its historical average?